Clinical trial / 2015
Middle-aged adults showed greater sensitivity to high-dose caffeine's disruptive effects on sleep quantity and quality than young adults.
In a double-blind cross-over study, the sleep of 22 young and 24 middle-aged adults was recorded using polysomnography under placebo and caffeine conditions (200 mg and 400 mg). Compared to placebo, caffeine increased sleep latency, shortened total sleep duration, and reduced sleep efficiency, with effects at the 400 mg dose being more pronounced in middle-aged adults. In both age groups, caffeine dose-dependently increased relative stage 1 sleep and reduced absolute and relative slow wave sleep as well as absolute rapid eye movement sleep. The 400 mg dose increased absolute stage 1 sleep in young adults but decreased absolute stage 2 sleep in middle-aged adults.
- Study type
- Double-blind cross-over trial
- Who was studied
- 22 young (23.5 ± 1.9 years) and 24 middle-aged (51.7 ± 11.5 years) adults
- What was measured
- Polysomnography sleep measures including latency, duration, efficiency, and sleep stages
THE PAPER
Sleep is more sensitive to high doses of caffeine in the middle years of life.
Robillard R, Bouchard M, Cartier A, Nicolau L, Carrier J. J Psychopharmacol, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.